Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating osteoarthritis with human oncostatin M antibodies

Method of treating osteoarthritis with human oncostatin M antibodies

US Patent 10941197 · Granted Mar 9, 2021

Estimated economic value: $186,799,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FLT3 agonist antibodies and uses thereof2025
Interferon beta antibodies and uses thereof2025
Anti-TIGIT antibodies2024
Anti-LAG3 antibodies and antigen-binding fragments2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy2024
Anti-BCMA antibody-drug conjugates and methods of use2024
Anti-CD73 antibodies and uses thereof2024
Anti-CD30L antibodies and uses thereof2024
Interferon beta antibodies and uses thereof2024
Humanized antibody for treating or preventing cognitive disorders, process for p2023
Neutralizing human anti-CD27 antibodies2023
Neutralizing human anti-CD27 antibodies2023